American Society of Hematology, Blood, 23(128), p. 2637-2641, 2016
DOI: 10.1182/blood-2016-05-718320
Full text: Unavailable
Key Points The type III TGF-β receptor is a marker that distinguishes “early” and “late” BFU-Es. TGF-β inhibitors increase early BFU-E cell self-renewal and total erythroblast production.